AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flanagan, F. L.
Right arrow Articles by Cooper, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flanagan, F. L.
Right arrow Articles by Cooper, J. D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 168, 417-424, Copyright © 1997 by American Roentgen Ray Society

ARTICLES

Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography

FL Flanagan, F Dehdashti, BA Siegel, DD Trask, SR Sundaresan, GA Patterson and JD Cooper
Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, St. Louis, MO 63110-1076, USA.

OBJECTIVE: The objective of this study was to assess the performance of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in the staging of cancer in patients with esophageal carcinoma. MATERIALS AND METHODS: The findings of FDG PET and of CT in the chest and upper abdomen of 36 patients with newly diagnosed esophageal carcinoma were compared with pathologic findings obtained either during a curative surgical procedure with tissue sampling (n = 29) or by tissue sampling alone (n = 7). RESULTS: Abnormal FDG uptake was identified on PET in the esophageal tumors of all patients. In 29 patients who underwent curative esophagectomy, PET and CT accurately revealed the extent of nodal disease in 76% (22/29) and 45% (13/29) of patients, respectively. In the seven patients who underwent tissue sampling instead of complete esophagectomy, PET revealed metastatic disease in five patients, all of whom avoided needless surgery. CT failed to reveal metastatic disease in these five patients. In addition, PET incidentally revealed an unsuspected primary long carcinoma in one patient. CONCLUSION: FDG PET is more sensitive than CT for revealing regional and distant metastases in patients with esophageal carcinoma. The use of PET in the staging of esophageal cancer may prove to be cost-effective by decreasing the number of unnecessary surgeries in patients with unresectable tumors.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
R. G. Berrisford, W.-L. Wong, D. Day, E. Toy, M. Napier, K. Mitchell, and S. Wajed
The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team
Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1112 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
J. F. Bruzzi, R. F. Munden, M. T. Truong, E. M. Marom, B. S. Sabloff, G. W. Gladish, R. B. Iyer, T.-S. Pan, H. A. Macapinlac, and J. J. Erasmus
PET/CT of Esophageal Cancer: Its Role in Clinical Management
RadioGraphics, November 1, 2007; 27(6): 1635 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. A. Huddart, M. J. O'Doherty, A. Padhani, G. J.S. Rustin, G. M. Mead, J. K. Joffe, P. Vasey, S. J. Harland, J. Logue, G. Daugaard, et al.
18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22 The NCRI Testis Tumour Clinical Study Group
J. Clin. Oncol., July 20, 2007; 25(21): 3090 - 3095.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
F. Banki, R. J. Mason, D. Oh, J. A. Hagen, S. R. DeMeester, J. C. Lipham, K. Tanaka, K. D. Danenberg, W. N. Yacoub, P. V. Danenberg, et al.
Plasma DNA as a Molecular Marker for Completeness of Resection and Recurrent Disease in Patients With Esophageal Cancer
Arch Surg, June 1, 2007; 142(6): 533 - 539.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. G. Little, T. W. Rice, B. Bybel, D. P. Mason, S. C. Murthy, G. W. Falk, L. A. Rybicki, and E. H. Blackstone
Is FDG-PET indicated for superficial esophageal cancer?
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 791 - 796.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
B. F. Meyers, R. J. Downey, P. A. Decker, R. J. Keenan, B. A. Siegel, R. J. Cerfolio, R. J. Landreneau, C. E. Reed, D. M. Balfe, F. Dehdashti, et al.
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial
J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 738 - 745.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
T. M. Blodgett, C. C. Meltzer, and D. W. Townsend
PET/CT: Form and Function
Radiology, February 1, 2007; 242(2): 360 - 385.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
W. Kneist, M. Schreckenberger, P. Bartenstein, C. Menzel, K. Oberholzer, and T. Junginger
Prospective Evaluation of Positron Emission Tomography in the Preoperative Staging of Esophageal Carcinoma
Arch Surg, October 1, 2004; 139(10): 1043 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H.L. van Westreenen, M. Westerterp, P.M.M. Bossuyt, J. Pruim, G.W. Sloof, J.J.B. van Lanschot, H. Groen, and J.Th.M. Plukker
Systematic Review of the Staging Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer
J. Clin. Oncol., September 15, 2004; 22(18): 3805 - 3812.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
P. A.M. Heeren, P. L. Jager, F. Bongaerts, H. van Dullemen, W. Sluiter, and J. Th.M. Plukker
Detection of Distant Metastases in Esophageal Cancer with 18F-FDG PET
J. Nucl. Med., June 1, 2004; 45(6): 980 - 987.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. L. van Westreenen, P. A.M. Heeren, P. L. Jager, H. M. van Dullemen, H. Groen, and J. Th.M. Plukker
Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission Tomography
Ann. Surg. Oncol., November 1, 2003; 10(9): 1100 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. V. Rasanen, E. I. T. Sihvo, M. J. Knuuti, H. R. I. Minn, M. E. S. Luostarinen, P. Laippala, T. Viljanen, and J. A. Salo
Prospective Analysis of Accuracy of Positron Emission Tomography, Computed Tomography, and Endoscopic Ultrasonography in Staging of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
Ann. Surg. Oncol., October 1, 2003; 10(8): 954 - 960.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
S. W. Fosko, W. Hu, T. F. Cook, and V. J. Lowe
Positron Emission Tomography for Basal Cell Carcinoma of the Head and Neck
Arch Dermatol, September 1, 2003; 139(9): 1141 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
Y. C. Yoon, K. S. Lee, Y. M. Shim, B.-T. Kim, K. Kim, and T. S. Kim
Metastasis to Regional Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma: CT versus FDG PET for Presurgical Detection— Prospective Study
Radiology, June 1, 2003; 227(3): 764 - 770.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
B B Chin and R L Wahl
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
Gut, June 1, 2003; 52(90004): iv23 - 29.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith
Clinical Role of FDG PET in Evaluation of Cancer Patients
RadioGraphics, March 1, 2003; 23(2): 315 - 340.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. J. Downey, T. Akhurst, D. Ilson, R. Ginsberg, M. S. Bains, M. Gonen, H. Koong, M. Gollub, B. D. Minsky, M. Zakowski, et al.
Whole Body 18FDG-PET and the Response of Esophageal Cancer to Induction Therapy: Results of a Prospective Trial
J. Clin. Oncol., February 1, 2003; 21(3): 428 - 432.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. A. Teefey, C. C. Hildeboldt, F. Dehdashti, B. A. Siegel, M. G. Peters, J. P. Heiken, J. J. Brown, E. G. McFarland, W. D. Middleton, D. M. Balfe, et al.
Detection of Primary Hepatic Malignancy in Liver Transplant Candidates: Prospective Comparison of CT, MR Imaging, US, and PET
Radiology, February 1, 2003; 226(2): 533 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
S. Himeno, S. Yasuda, H. Shimada, T. Tajima, and H. Makuuchi
Evaluation of Esophageal Cancer by Positron Emission Tomography
Jpn. J. Clin. Oncol., September 1, 2002; 32(9): 340 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
S. M. Wren, P. Stijns, and S. Srinivas
Positron Emission Tomography in the Initial Staging of Esophageal Cancer
Arch Surg, September 1, 2002; 137(9): 1001 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. S. Parmar, J. B. Zwischenberger, A. L. Reeves, and I. Waxman
Clinical impact of endoscopic ultrasound-guided fine needle aspiration of celiac axis lymph nodes (M1a disease) in esophageal cancer
Ann. Thorac. Surg., March 1, 2002; 73(3): 916 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
B. Rydzewski, F. Dehdashti, B. A. Gordon, S. A. Teefey, S. M. Strasberg, and B. A. Siegel
Usefulness of Intraoperative Sonography for Revealing Hepatic Metastases from Colorectal Cancer in Patients Selected for Surgery After Undergoing FDG PET
Am. J. Roentgenol., February 1, 2002; 178(2): 353 - 358.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. A. Weber, K. Ott, K. Becker, H.-J. Dittler, H. Helmberger, N. E. Avril, G. Meisetschlager, R. Busch, J.-R. Siewert, M. Schwaiger, et al.
Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging
J. Clin. Oncol., June 15, 2001; 19(12): 3058 - 3065.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. Kim, S. J. Park, B.-T. Kim, K. S. Lee, and Y. M. Shim
Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography
Ann. Thorac. Surg., January 1, 2001; 71(1): 290 - 294.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
P. Flamen, A. Lerut, E. Van Cutsem, J. P. Cambier, A. Maes, W. De Wever, M. Peeters, P. De Leyn, D. Van Raemdonck, and L. Mortelmans
The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1085 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Flamen, A. Lerut, E. Van Cutsem, W. De Wever, M. Peeters, S. Stroobants, P. Dupont, G. Bormans, M. Hiele, P. De Leyn, et al.
Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma
J. Clin. Oncol., September 18, 2000; 18(18): 3202 - 3210.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
S. J. Skehan, A. L. Brown, M. Thompson, J. E. M. Young, G. Coates, and C. Nahmias
Imaging Features of Primary and Recurrent Esophageal Cancer at FDG PET
RadioGraphics, May 1, 2000; 20(3): 713 - 723.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
K. L. Berger, S. A. Nicholson, F. Dehdashti, and B. A. Siegel
FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features
Am. J. Roentgenol., April 1, 2000; 174(4): 1005 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V. J Lowe and K. S Naunheim
Current role of positron emission tomography in thoracic oncology
Thorax, August 1, 1998; 53(8): 703 - 712.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
J. D. Luketich, P. R. Schauer, C. C. Meltzer, R. J. Landreneau, G. K. Urso, D. W. Townsend, P. F. Ferson, R. J. Keenan, and C. P. Belani
Role of Positron Emission Tomography in Staging Esophageal Cancer
Ann. Thorac. Surg., September 1, 1997; 64(3): 765 - 769.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. I. Block, G. A. Patterson, R. S. Sundaresan, M. S. Bailey, F. L. Flanagan, F. Dehdashti, B. A. Siegel, and J. D. Cooper
Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography
Ann. Thorac. Surg., September 1, 1997; 64(3): 770 - 776.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Roentgen Ray Society.